Reasons for therapeutic inertia when managing hypertension in clinical practice in non-Western countries

Journal of Human Hypertension

Volumn 23, Issue 3, 2009, Pages 151-159

  Ferrari, P ^a  

^a FREMANTLE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIURETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PHYSICIAN; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; REFERENCE VALUE; SELF EXAMINATION; SYSTOLIC BLOOD PRESSURE; UNSPECIFIED SIDE EFFECT;

AGED; ANTIHYPERTENSIVE AGENTS; ATTITUDE OF HEALTH PERSONNEL; AWARENESS; BLOOD PRESSURE; CLINICAL COMPETENCE; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; FEMALE; GOALS; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 60549098789     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2008.117     Document Type: Article

References (27)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206-1252.
2. Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983-1992.
3. JNC 6. National High Blood Pressure Education Program. The Sixth Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157 2413-2446.
4. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290: 199-206.
5. Ferrari P, Hess L, Pechere-Bertschi A, Muggli F, Burnier M. Reasons for not intensifying antihypertensive treatment (RIAT): A primary care antihypertensive intervention study. J Hypertens 2004; 22: 1221-1229.
6. Dusing R, Weisser B, Mengden T, Vetter H. Changes in antihypertensive therapy - the role of adverse effects and compliance. Blood Press 1998; 7: 313-315.
7. Degli Esposti E, Sturani A, Di Martino M, Falasca P, Novi MV, Baio G et al. Long-term persistence with antihypertensive drugs in new patients. J Hum Hypertens 2002; 16: 439-444.
8. Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: Blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med 2000; 160: 2281-2286.
9. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001; 345: 479-486.
10. Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension 2006; 47: 345-351.
11. Ferrari P, Kim SK, Wu CJ, Pham NV, Ageev F, Hermosillo LD et al. Aim, design and methods of the 'reasons for not intensifying antihypertensive treatment' (RIAT): An international registry in essential hypertension. J Hum Hypertens 2006; 20: 31-36.
12. Rehman SU, Hutchison FN, Hendrix K, Okonofua EC, Egan BM. Ethnic differences in blood pressure control among men at Veterans Affairs clinics and other health care sites. Arch Intern Med 2005; 165 1041-1047.
13. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M et al Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-313.
14. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-2997.
15. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L et al Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial. Lancet 2004; 363: 2022-2031.
16. Poulter NR, Wedel H, Dahlöf B, Sever PS, Beevers DG, Caulfield M et al. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet 2005; 366: 907-913.
17. Hagemeister J, Schneider CA, Barabas S, Schadt R, Wassmer G, Mager G et al. Hypertension guidelines and their limitations-the impact of physicians' compliance as evaluated by guideline awareness. J Hypertens 2001; 19: 2079-2086.
18. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002; 162: 413-420.
19. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: A randomized controlled trial. JAMA 2006; 296: 2563-2571.
20. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 2006; 19: 1190-1196.
21. Preston RA, Materson BJ, Reda DJ, Williams DW. Placebo-associated blood pressure response and adverse effects in the treatment of hypertension: observations from a Department of Veterans Affairs Cooperative Study. Arch Intern Med 2000; 160: 1449-1454.
22. Nietert PJ,Wessell AM, Feifer C, Ornstein SM. Effect of terminal digit preference on blood pressure measurement and treatment in primary care. Am J Hypertens 2006; 19: 147-152.
23. Graves JW, Bailey KR, Grossardt BR, Gullerud RE, Meverden RA, Grill DE et al. The impact of observer and patient factors on the occurrence of digit preference for zero in blood pressure measurement in a hypertension specialty clinic: Evidence for the need of continued observation. Am J Hypertens 2006; 19: 567-572.
24. Cranney M, Warren E, Barton S, Gardner K, Walley T. Why do GPs not implement evidence-based guidelines? A descriptive study. Fam Pract 2001; 18: 359-363.
25. Burnier M. Blood pressure control and the implementation of guidelines in clinical practice: Can we fill the gap? J Hypertens 2002; 20 1251-1253.
26. Romain TM, Patel RP, Heaberlin AM, Zarowitz BJ. Assessment of factors influencing blood pressure control in a managed care population. Pharmacotherapy 2003; 23: 1060-1070.
27. Carter BL. Implementing the new guidelines for hypertension: JNC 7, ADA, WHO-ISH. J Manag Care Pharm 2004; 10: S18-S25.